NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 8 filers reported holding NOVELION THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $61,000 | -7.6% | 84,353 | -1.2% | 0.00% | – |
| Q2 2019 | $66,000 | -36.5% | 85,409 | +0.6% | 0.00% | – |
| Q1 2019 | $104,000 | -26.8% | 84,881 | -48.8% | 0.00% | – |
| Q4 2018 | $142,000 | -15.5% | 165,802 | +191.4% | 0.00% | – |
| Q3 2018 | $168,000 | -17.2% | 56,898 | +2.7% | 0.00% | – |
| Q2 2018 | $203,000 | -31.2% | 55,425 | -34.4% | 0.00% | – |
| Q1 2018 | $295,000 | +20.9% | 84,511 | +7.9% | 0.00% | – |
| Q4 2017 | $244,000 | -9.0% | 78,354 | +105.3% | 0.00% | – |
| Q3 2017 | $268,000 | +13.1% | 38,160 | +48.4% | 0.00% | – |
| Q2 2017 | $237,000 | – | 25,722 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|